Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 18.80.
Forward PE Ratio (18.80) = Close Price ($36.77) / Consensus Forward EPS ($2.00)
FORWARD PE RATIO
18.80
SECTOR MEDIAN · HEALTHCARE
20.23
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
-7.07%
vs the sector median at left
Teva Pharmaceutical Industries Limited
Market Cap
$42.82B
Forward PE Ratio
18.80
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) | $42.82B | 18.80 |
| IQVIA Holdings Inc. (IQV)vs › | $43.10B | 20.23 |
| Agilent Technologies, Inc. (A)vs › | $43.39B | 26.02 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.62B | 36.90 |
| Humana Inc. (HUM)vs › | $46.95B | 42.89 |
| Alcon Inc. (ALC)vs › | $34.95B | 20.49 |
| ResMed Inc. (RMD)vs › | $34.73B | 21.19 |
| DexCom, Inc. (DXCM)vs › | $34.14B | 33.47 |
| Edwards Lifesciences Corporation (EW)vs › | $51.97B | 29.97 |
| Becton, Dickinson and Company (BDX)vs › | $52.22B | 14.85 |
Trailing P/E
62.7
reported TTM EPS
Forward P/E
18.8
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $2.00 implies +233.3% EPS growth vs the reported trailing $0.60.
At today's $36.77 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $2.00 | $1.94 – $2.06 | 7 | 18.4x |
| 2027-12-31 | $3.07 | $3.03 – $3.13 | 7 | 12.0x |
| 2028-12-31 | $3.44 | $3.16 – $3.88 | 3 | 10.7x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
